Pancreatic islet of Langerhans' cytoarchitecture and ultrastructure in normal glucose tolerance and in type 2 diabetes mellitus

F Folli, S La Rosa, G Finzi, AM Davalli, A Galli, EJ Dick, C Perego, RG Mendoza

Research output: Contribution to journalArticle

Abstract

While a number of structural and cellular abnormalities occur in the islet of Langerhans in diabetes, and in particular in type 2 diabetes, the focus has been mostly on the insulin producing β-cells and only more recently on glucagon producing α- and δ-cells. There is ample evidence that in type 2 diabetes mellitus (T2DM), in addition to a progressive decline in β-cell function and associated insulin resistance in a number of insulin-sensitive tissues, alterations in glucagon secretion are also present and may play an important role in the pathogenesis of hyperglycemia both in the fasting and in the postprandial state. Recently, a number of studies have showed that there are also functional and structural alterations in glucagon-producing α-cells and somatostatin-producing δ-cells. Thus, it is becoming increasingly clear that multiple cellular alterations of multiple cell types occur, which adds even more complexity to our understanding of the pathophysiology of this common and severe disease. We believe that persistent efforts to increase the understanding of the pathophysiology of hormone secretion in the islets of Langerhans will also improve our capability to better prevent and treat diabetes mellitus. © 2018 John Wiley & Sons Ltd
Original languageEnglish
Pages (from-to)137-144
Number of pages8
JournalDiabetes, Obesity and Metabolism
Volume20
Issue numberSuppl
DOIs
Publication statusPublished - 2018

Fingerprint

Islets of Langerhans
Type 2 Diabetes Mellitus
Glucose
Glucagon
Insulin
Somatostatin-Secreting Cells
Hyperglycemia
Insulin Resistance
Fasting
Diabetes Mellitus
Hormones

Cite this

Pancreatic islet of Langerhans' cytoarchitecture and ultrastructure in normal glucose tolerance and in type 2 diabetes mellitus. / Folli, F; La Rosa, S; Finzi, G; Davalli, AM; Galli, A; Dick, EJ; Perego, C; Mendoza, RG.

In: Diabetes, Obesity and Metabolism, Vol. 20, No. Suppl, 2018, p. 137-144.

Research output: Contribution to journalArticle

Folli, F, La Rosa, S, Finzi, G, Davalli, AM, Galli, A, Dick, EJ, Perego, C & Mendoza, RG 2018, 'Pancreatic islet of Langerhans' cytoarchitecture and ultrastructure in normal glucose tolerance and in type 2 diabetes mellitus', Diabetes, Obesity and Metabolism, vol. 20, no. Suppl, pp. 137-144. https://doi.org/10.1111/dom.13380
Folli, F ; La Rosa, S ; Finzi, G ; Davalli, AM ; Galli, A ; Dick, EJ ; Perego, C ; Mendoza, RG. / Pancreatic islet of Langerhans' cytoarchitecture and ultrastructure in normal glucose tolerance and in type 2 diabetes mellitus. In: Diabetes, Obesity and Metabolism. 2018 ; Vol. 20, No. Suppl. pp. 137-144.
@article{c3e21e3fdf644f9d9677b3f76fdfa6d0,
title = "Pancreatic islet of Langerhans' cytoarchitecture and ultrastructure in normal glucose tolerance and in type 2 diabetes mellitus",
abstract = "While a number of structural and cellular abnormalities occur in the islet of Langerhans in diabetes, and in particular in type 2 diabetes, the focus has been mostly on the insulin producing β-cells and only more recently on glucagon producing α- and δ-cells. There is ample evidence that in type 2 diabetes mellitus (T2DM), in addition to a progressive decline in β-cell function and associated insulin resistance in a number of insulin-sensitive tissues, alterations in glucagon secretion are also present and may play an important role in the pathogenesis of hyperglycemia both in the fasting and in the postprandial state. Recently, a number of studies have showed that there are also functional and structural alterations in glucagon-producing α-cells and somatostatin-producing δ-cells. Thus, it is becoming increasingly clear that multiple cellular alterations of multiple cell types occur, which adds even more complexity to our understanding of the pathophysiology of this common and severe disease. We believe that persistent efforts to increase the understanding of the pathophysiology of hormone secretion in the islets of Langerhans will also improve our capability to better prevent and treat diabetes mellitus. {\circledC} 2018 John Wiley & Sons Ltd",
author = "F Folli and {La Rosa}, S and G Finzi and AM Davalli and A Galli and EJ Dick and C Perego and RG Mendoza",
year = "2018",
doi = "10.1111/dom.13380",
language = "English",
volume = "20",
pages = "137--144",
journal = "Diabetes, Obesity and Metabolism",
issn = "1462-8902",
publisher = "Wiley-Blackwell",
number = "Suppl",

}

TY - JOUR

T1 - Pancreatic islet of Langerhans' cytoarchitecture and ultrastructure in normal glucose tolerance and in type 2 diabetes mellitus

AU - Folli, F

AU - La Rosa, S

AU - Finzi, G

AU - Davalli, AM

AU - Galli, A

AU - Dick, EJ

AU - Perego, C

AU - Mendoza, RG

PY - 2018

Y1 - 2018

N2 - While a number of structural and cellular abnormalities occur in the islet of Langerhans in diabetes, and in particular in type 2 diabetes, the focus has been mostly on the insulin producing β-cells and only more recently on glucagon producing α- and δ-cells. There is ample evidence that in type 2 diabetes mellitus (T2DM), in addition to a progressive decline in β-cell function and associated insulin resistance in a number of insulin-sensitive tissues, alterations in glucagon secretion are also present and may play an important role in the pathogenesis of hyperglycemia both in the fasting and in the postprandial state. Recently, a number of studies have showed that there are also functional and structural alterations in glucagon-producing α-cells and somatostatin-producing δ-cells. Thus, it is becoming increasingly clear that multiple cellular alterations of multiple cell types occur, which adds even more complexity to our understanding of the pathophysiology of this common and severe disease. We believe that persistent efforts to increase the understanding of the pathophysiology of hormone secretion in the islets of Langerhans will also improve our capability to better prevent and treat diabetes mellitus. © 2018 John Wiley & Sons Ltd

AB - While a number of structural and cellular abnormalities occur in the islet of Langerhans in diabetes, and in particular in type 2 diabetes, the focus has been mostly on the insulin producing β-cells and only more recently on glucagon producing α- and δ-cells. There is ample evidence that in type 2 diabetes mellitus (T2DM), in addition to a progressive decline in β-cell function and associated insulin resistance in a number of insulin-sensitive tissues, alterations in glucagon secretion are also present and may play an important role in the pathogenesis of hyperglycemia both in the fasting and in the postprandial state. Recently, a number of studies have showed that there are also functional and structural alterations in glucagon-producing α-cells and somatostatin-producing δ-cells. Thus, it is becoming increasingly clear that multiple cellular alterations of multiple cell types occur, which adds even more complexity to our understanding of the pathophysiology of this common and severe disease. We believe that persistent efforts to increase the understanding of the pathophysiology of hormone secretion in the islets of Langerhans will also improve our capability to better prevent and treat diabetes mellitus. © 2018 John Wiley & Sons Ltd

U2 - 10.1111/dom.13380

DO - 10.1111/dom.13380

M3 - Article

VL - 20

SP - 137

EP - 144

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

SN - 1462-8902

IS - Suppl

ER -